Evolent Health (EVH) Stock Price, News & Analysis

Company Overview

Evolent Health, Inc. (NYSE: EVH) is a healthcare technology and services company focused on helping health plans and healthcare providers transition to value-based care. Its platform and services are designed to support the management of patient populations, improve clinical outcomes, and align healthcare payments with the quality and cost effectiveness of care.

The company provides solutions that may include specialty care management, population health management, administrative services, payment integrity, clinical decision support, and technology for coordinating care. Evolent works with health plans, providers, and other healthcare organizations across areas such as oncology, cardiology, musculoskeletal care, and other high-cost or complex specialties.

Founded in 2011, Evolent primarily serves the U.S. healthcare market. The company was co-founded by Frank Williams, who previously served as its chief executive, and Seth Blackley, who has served as chief executive officer. Evolent has expanded its offerings through organic development and acquisitions focused on technology-enabled specialty care and value-based healthcare services.

Key Stats

• Today's Range: $3.64 to $3.79
• 50-Day Range: $3.05 to $6.19
• 52-Week Range: $2.10 to $9.63
• Volume: 4.20 million shs
• Average Volume: 2.26 million shs
• Market Capitalization: $415.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.96
• Consensus Rating: Moderate Buy

Evolent Health Stock Analysis - MarketRank™

Evolent Health scored higher than 58% of companies evaluated by MarketBeat, and ranked 360th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Evolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 11 buy ratings, 4 hold ratings, and 1 sell rating.

Upside Potential

Evolent Health has a consensus price target of $5.96, representing about 62.4% upside from its current price of $3.67.

Amount of Analyst Coverage

Evolent Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Evolent Health are expected to grow in the coming year, from ($0.25) to ($0.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Evolent Health is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Evolent Health is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Evolent Health has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.89% of the float of Evolent Health has been sold short.

Short Interest Ratio / Days to Cover

Evolent Health has a short interest ratio ("days to cover") of 5.83.

Change versus previous month

Short interest in Evolent Health has recently decreased by 1.92%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Evolent Health does not currently pay a dividend.

Dividend Growth

Evolent Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.34

News Sentiment

Evolent Health has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Evolent Health this week, compared to 2 articles on an average week.

Search Interest

Only 5 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.

MarketBeat Follows

1 people have added Evolent Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $329,460.00 in company stock.

Percentage Held by Insiders

1.48% of the stock of Evolent Health is held by insiders.

Percentage Held by Institutions

Evolent Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/17/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:EVH
• CIK: 1628908
• Web: www.evolenthealth.com
• Phone: (571) 389-6000
• Fax: 571-389-6001
• Employees: 4,200
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Evolent Health: $5.96
• High Price Target: $10.00
• Low Price Target: $3.00
• Potential Upside/Downside: +62.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$534.51 million
• Net Margins: -24.08%
• Pretax Margin: -23.94%
• Return on Equity: -4.27%
• Return on Assets: -1.06%

Debt

• Debt-to-Equity Ratio: 2.52
• Current Ratio: 1.24
• Quick Ratio: 1.24

Sales & Book Value

• Annual Sales: $1.88 billion
• Price / Sales: 0.22
• Cash Flow: $4.59 per share
• Price / Cash Flow: 0.80
• Book Value: $3.53 per share
• Price / Book: 1.04

Miscellaneous

• Outstanding Shares: 113,060,000
• Free Float: 111,386,000
• Market Cap: $415.27 million
• Optionable: Optionable
• Beta: 0.84